Alaunos Therapeutics, Inc.
TCRT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001107421
No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Alaunos Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 50 | 1 | 29 | −20 |
| SharesConverted for a 1-for-10 split | 241.0K | 22.2K | 192.1K | −26.7K (−12.2%) |
| Value | $1.69M | $155.5K | $622.8K | −$912.6K (−59.4%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 22,233 | $71.6K | 0.00% |
| Bokf, NA | 66 | $181 | 0.00% |
| Harbour Investments, Inc. | 46 | $148 | 0.00% |
| Chilton Capital Management LLC | 16 | $52 | 0.00% |
Sold out (24)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| State Street Corp | 50,205 | $35.1K |
| Commerce Bank | 29,132 | $20.4K |
| Northern Trust Corp | 28,976 | $20.3K |
| Sanctuary Advisors, LLC | 12,299 | $16.2K |
| Citadel Advisors LLC | 16,905 | $11.8K |
| Allred Capital Management, LLC | 16,866 | $11.8K |
| PFG Investments, LLC | 16,166 | $11.3K |
| Fortis Group Advisors, LLC | 13,999 | $9.79K |
| Dimensional Fund Advisors LP | 12,709 | $8.88K |
| Atria Wealth Solutions, Inc. | 11,145 | $7.79K |
| Two Sigma Securities, LLC | 10,233 | $7.15K |
| HRT Financial LP | 10,480 | $7.00K |
| Rhumbline Advisers | 391 | $273 |
| Key Financial Inc | 245 | $171 |
| Redwood Wealth Management Group, LLC | 200 | $140 |
| Northwestern Mutual Wealth Management Co | 166 | $116 |
| Qube Research & Technologies Ltd | 105 | $73 |
| PFS Partners, LLC | 66 | $47 |
| JPMorgan Chase & Co | 12 | $8 |
| Family Firm, Inc. | 7 | $5 |
| Trust Co of Vermont | 6 | $4 |
| Ashton Thomas Private Wealth, LLC | 5 | $3 |
| Royal Bank of Canada | 353 | $0 |
| Simplex Trading, LLC | 267 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 222,440 | $155.5K |